Kyle Walters

Kyle Walters is an experienced Director of Program Management specializing in biotech and pharmaceutical project execution, currently serving at AstraZeneca. Previously, Kyle held various roles at Apobiologix, where they contributed to the development and commercialization of biologic products, and at PAREXEL, where they led global oncology trials. At Turnstone Biologics, Kyle improved operational efficiency and managed significant budgets, while at Notch Therapeutics, they focused on developing cell therapy products. Kyle earned an Honours BSc in Biomedical Toxicology from the University of Guelph and a Post Graduate Certificate in Regulatory Affairs from Humber College.